PRASOLCHEM

Concall Schedule Concall Date: 16th November 2026 Concall Time: 10:00 am onwards

Concall Schedule Concall Date: 16th November 2026 Concall Time: 10:00 am onwards

Current scenario - Delivered record quarterly revenue of ₹413 crores, registering a YoY growth of 38.6%, driven by higher realizations along with single-digit domestic volume growth. - EBITDA stood at ₹58 crores, up 86.1% YoY, while PAT stood at ₹38 crores, up 122.2% YoY. - H1 FY27 revenue from operations reached ₹846 crores with EBITDA of ₹148 crores and PAT of ₹99 crores, already surpassing last year's full performance metrics. Changes in trends - Net working capital cycle increased from 63 days to 76 days due to lower creditor days from diversifying the raw material sourcing base to ensure supply chain resilience. - Raw material prices remained elevated and shipping lead times increased, leading to higher inventory holding. Management Guidance & Outlook - Reaffirmed full-year FY27 guidance of revenue in the range of ₹1,550 crores to ₹1,650 crores and EBITDA of ₹240 crores to ₹250 crores, excluding geopolitical price gains. - Targeted medium-term growth to reach ₹2,800 crores to ₹3,000 crores in revenue over the next 5 years. Capex - Incurred ~₹75 crores towards Phase 1 capacity expansion projects in H1 FY27 and plan to invest another ₹75 to ₹100 crores by the end of the year, adding ~60,000 tonnes of capacity. - Phase 2 plans of ₹250 to ₹300 crores are on track for R&D-led products in mining chemicals, lubricants, and pharma over the next 2.5 years. Growth Drivers - Demand from domestic and international customers remains healthy with strong order books and customer approvals across geographies.

- Prasol Chemicals Limited informed the exchanges about the audio recording link of the Quarterly Earnings Conference Call for Q2 FY27 results held on November 3, 2026. - The recording has been made available on the company's official website.

- Prasol Chemicals Limited submitted a statement confirming no deviation or variation in the utilization of IPO proceeds for the quarter ended September 30, 2026. - The funds raised through the Initial Public Offering amounted to ₹80 Millions (or 800 Millions). - The audit committee and auditors reviewed the utilization and reported no comments or discrepancies.

Q2 FY27 Consolidated Revenue Rs.412.6Cr vs Rs.297.6Cr (▲38.6% YoY) EBITDA Rs.57.7Cr vs Rs.31.0Cr (▲86.1% YoY) PAT Rs.37.9Cr vs Rs.17.1Cr (▲122.2% YoY) EBITDA Margin 14.0% vs 10.4% (▲360bps) Company remains on track to deliver FY27 guidance of revenue Rs.1,550-1,650 crores and EBITDA Rs.240-250 crores.

Q2 FY27 Standalone Revenue ₹412.57 Cr vs ₹297.65 Cr (▲38.6% YoY) EBITDA ₹57.77 Cr vs ₹31.05 Cr (▲86.0% YoY) PAT ₹37.98 Cr vs ₹17.11 Cr (▲121.9% YoY) EBITDA Margin 14.00% vs 10.43% (▲357bps)

Concall Schedule Concall Date: Tuesday, November 3, 2026 Concall Time: 11:00 AM IST Purpose: To discuss Q2 FY27 results with investors and analysts.

- Prasol Chemicals Limited informed the exchanges regarding the update of its Corporate Identification Number (CIN) following its listing on BSE and NSE. - The CIN has been updated from U99999MH1992PLC065026 to L99999MH1992PLC065026. - The company status on the MCA master data has been officially changed from "Unlisted" to "Listed".

Prasol Chemicals Limited held its maiden earnings conference call for Q1 FY27 on September 29, 2026, following its recent IPO listing on September 16, 2026. Management highlighted a strong financial performance in Q1 FY27, supported by steady volume growth, better product mix, and higher inventory realisations driven by global supply chain disruptions. For FY27, the company expects to deliver a revenue of INR1,550 crores to INR1,650 crores and an adjusted EBITDA of INR240 crores to INR250 crores (excluding inventory and forex gains). The company has outlined a Phase 1 capital expenditure of INR250 crores to INR300 crores for debottlenecking and expanding capacities for existing products, which is expected to generate INR500 crores to INR550 crores of peak revenue.

- Prasol Chemicals Limited informed the exchange regarding the audio recording link of the Quarterly Earnings Conference Call for Q1 FY27 results. - The conference call was held on Tuesday, September 29, 2026, at 11:00 a.m. - The recording is made available on the company's website under the investor relations section.

Q1 FY27 Consolidated Revenue ₹433.60Cr vs ₹319.60Cr (▲35.67% YoY) EBITDA ₹90.30Cr vs ₹40.60Cr (▲122.41% YoY) PAT ₹61.00Cr vs ₹24.30Cr (▲150.62% YoY) EBITDA Margin 20.82% vs 12.70% (▲812bps) Company successfully completed its IPO listing on September 16, 2026. Management guided for FY27 revenue of ₹1,550-1,650 crores and EBITDA of ₹240-250 crores (excluding geopolitical supply chain issues and forex impacts).

Q1 FY27 Standalone Revenue ₹4,336.46 Mn vs ₹3,195.60 Mn (▲36% YoY) EBITDA ₹902.79 Mn vs ₹406.01 Mn (▲122% YoY) PAT ₹610.23 Mn vs ₹243.38 Mn (▲151% YoY) EBITDA Margin 20.82% vs 12.71% (▲811bps)

- Trading window closed from October 1, 2026. - Closure relates to Q2/H1 FY27 financial results declaration. - Window will reopen 48 hours after results announcement.